10 Nov 2022 , 08:01 AM
Net profit of Jagsonpal Pharmaceuticals rose 58.69% to Rs 10.41 crore in the quarter ended September 2022 as against Rs 6.56 crore during the previous quarter ended September 2021. Sales rose 1.75% to Rs 60.53 crore in the quarter ended September 2022 as against Rs 59.49 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 60.53 | 59.49 | 2 |
| OPM % | 21.31 | 15.82 | – |
| PBDT | 13.99 | 9.63 | 45 |
| PBT | 13.79 | 9.40 | 47 |
| NP | 10.41 | 6.56 | 59 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
